UPDATE: Argus Downgrades Altria (MO) to Hold

May 5, 2021 7:16 AM EDT
Get Alerts MO Hot Sheet
Price: $47.43 +0.87%

Rating Summary:
    12 Buy, 10 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 11 | Down: 5 | New: 41
Trade Now! 
Join SI Premium – FREE
(Updated - May 5, 2021 7:20 AM EDT)

Argus analyst David Coleman downgraded Altria (NYSE: MO) from Buy to Hold.

The analyst comments "We are lowering our rating on Altria Group Inc. (NYSE: MO) to HOLD from BUY. The company manufactures and sells cigarettes, smokeless tobacco products, and alcoholic beverages in the United States and abroad. Altria has been growing through investments in companies with products that diversify its portfolio, including the purchase of a 45% stake in Cronos Group, a Canadian cannabinoid producer, and a 35% stake in popular e-cigarette maker JUUL Labs. The company also pays a solid dividend with a yield of about 7%. However, Altria has seen a sharp decline in the value of its JUUL investment, and is facing increased legislative and regulatory risks. In particular, the FDA recently said that it planned to ban menthol cigarettes, and was considering rules that would reduce cigarette nicotine to nonaddictive levels. In addition, the Biden administration may raise excise taxes on cigarettes."

For an analyst ratings summary and ratings history on Altria click here. For more ratings news on Altria click here.

Shares of Altria closed at $48.00 yesterday.

You May Also Be Interested In

Related Categories

Analyst Comments, Downgrades

Related Entities

Argus, FDA